Overview

Shire Pharmaceuticals, now a subsidiary of Takeda Pharmaceutical Company, was a global biopharmaceutical company focused on serving people with rare diseases and other highly specialized conditions. After its acquisition in 2019, Shire's operations have been integrated into Takeda's broader pharmaceutical operations.

Therapeutic areas

HematologyImmunologyNeuroscienceGenetic DiseasesInternal Medicine

FDA compliance signals

1 FDA enforcement record linked to this company.

  • warning_letter2009-11-05

    FDA Warning Letter (drug product)

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.